43 -5 (79) 2025 - A.Z. Kutmanova, S.M.Akhunbaev - COVID-19 AND ITS ECHOES: A PROSPECTIVE STUDY OF POST-COVID SYMPTOMS

COVID-19 AND ITS ECHOES: A PROSPECTIVE STUDY OF POST-COVID SYMPTOMS

A.Z. Kutmanova - International Higher School of Medicine, Bishkek, Kyrgyzstan

S.M.Akhunbaev - International Higher School of Medicine, Bishkek, Kyrgyzstan

B.T.Abdimunova - Osh State University, Osh, Kyrgyz Republic

S.T.Zholdoshev - Osh State University, Osh, Kyrgyz Republic

K.D.Kalybekova - Osh State University, Osh, Kyrgyz Republic

Resume

Introduction. Postcovoid syndrome combines a wide range of long-lasting and new symptoms that persist or occur after a coronavirus infection. Goal. To evaluate the clinical manifestations and duration of symptoms of postcovoid syndrome in residents of Osh region of Kyrgyzstan. Materials and methods. A prospective cohort analysis of 360 patients with laboratory-confirmed COVID-19 admitted to Osh Interregional Clinical Hospital between June 2020 and May 2022 was conducted. Long-term clinical follow-up was carried out for up to 96 weeks after the acute phase of the disease. Statistical data processing was performed using the Kraskel–Wallis criteria and the χ2-Pearson test, the results are presented in the form of median (IQR) and percentages. Results. Postcovoid syndrome was reported in 174 (48.3%) of the observed patients. The most persistent were asthenic syndrome (general weakness, fatigue, sleep disorders) and neurological disorders (headaches, cognitive disorders), as well as respiratory symptoms (shortness of breath, myalgia). In the first 24-48 weeks, loss of taste and sense of smell, shortness of breath and myalgia persisted. Arthralgia (81.1%) and increased anxiety (63.3%), as well as gastroenterological, metabolic and cardiovascular symptoms dominated among the new manifestations. Conclusion. Postcovoid syndrome is characterized by both persistent symptoms of acute COVID-19 for more than a year and the appearance of new clinical phenotypes

Keywords: Long-term COVID (Long COVID), post-acute effects of SARS-CoV-2, persistent symptoms, multisystem damage, cognitive impairment, loss of taste and sense of smell, arthralgia, anxiety

First page

209

Last page

213

For citation:A.Z. Kutmanova, S.M.Akhunbaev, B.T.Abdimunova, S.T.Zholdoshev, K.D.Kalybekova - COVID-19 AND ITS ECHOES: A PROSPECTIVE STUDY OF POST-COVID SYMPTOMS//New Day in Medicine 5(79)2025 209-213 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. WHO A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. [(accessed on 3 March 2022)]. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_ case_ definition-2021.1
  2. Clinical Services, Systems. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organi zation; 6 Oct 2021 [cited 11 May 2022]. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID- 19_condition-Clinical_case_definition-2021.1
  3. Шинагареева К.Р., Ашихмин Я.И. Новая коронавирусная инфекция, постковидный синдром (long COVID): эпидемиология, патофизиология, возможности терапии. Здравоохранение Кыргызстана научно-практический журнал 2023, № 4, с.58-67. https://dx.doi.org/10.51350/zdravkg2023.4.12.6.58.67
  4. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–615. doi: 10.1038/s41591-021-01283-z.
  5. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22. PMID: 34024217; PMCID: PMC8146298.
  6. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22. PMID: 34024217; PMCID: PMC8146298.
  7. Hill EL, Mehta HB, Sharma S, Mane K, Singh SK, Xie C, Cathey E, Loomba J, Russell S, Spratt H, DeWitt PE, Ammar N, Mad lock-Brown C, Brown D, McMurry JA, Chute CG, Haendel MA, Moffitt R, Pfaff ER, Bennett TD; N3C Consortium; and the RE COVER Consortium. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study. BMC Public Health. 2023 Oct 25;23(1):2103. doi: 10.1186/s12889-023-16916-w. PMID: 37880596; PMCID: PMC10601201.
  8. Coleman B, Casiraghi E, Callahan TJ, Blau H, Chan LE, Laraway B, Clark KB, Re'em Y, Gersing KR, Wilkins KJ, Harris NL, Valentini G, Haendel MA, Reese JT, Robinson PN. Association of post-COVID phenotypic manifestations with new-onset psy chiatric disease. Transl Psychiatry. 2024 Jun 8;14(1):246. doi: 10.1038/s41398-024-02967-z. PMID: 38851761; PMCID: PMC11162470.
  9. CDC . National center for immunization and respiratory diseases (NCIRD) DoVD. long COVID or post-COVID conditions (2022). Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/.
  10. Lupi L, Vitiello A, Parolin C, Calistri A, Garzino-Demo A. The Potential Role of Viral Persistence in the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Pathogens. 2024 May 8;13(5):388. doi: 10.3390/pathogens13050388. PMID: 38787240; PMCID: PMC11123686

    file

    download